Due to manufacturing issues, Pediarix® (DTaP-IPV-Hep B combination) vaccine from GlaxoSmithKline (GSK) is presently unavailable for VFC patients. No Pediarix® orders are being accepted for VFC until further notice. Vaccine order requests for Pediarix® placed after April 20th have been cancelled.

VFC providers should continue to administer DTaP, IPV, Hep B, and Hib-containing vaccines on schedule to all patients. Single-dose vaccines are still available in full supply.

See the full May 2013 Pediarix® Health Advisory for full recommendations.